Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study
B Zhu, E Edson-Heredia, JL Gatz, J Guo, CL Shuler - Clinical therapeutics, 2013 - Elsevier
Background Biologic therapies have been used in patients with psoriatic arthritis (PsA) who
have been inadequately treated with conventional disease-modifying anti-rheumatic drugs
(DMARDs). Objective Examine treatment patterns and health care costs among patients with
PsAs who initiated biologic therapy either as monotherapy or adjunctively with traditional
DMARDs. Methods The MarketScan® database was used to identify adults with PsA who
initiated therapy with a biologic (with first use identified as index date). Patients were …
have been inadequately treated with conventional disease-modifying anti-rheumatic drugs
(DMARDs). Objective Examine treatment patterns and health care costs among patients with
PsAs who initiated biologic therapy either as monotherapy or adjunctively with traditional
DMARDs. Methods The MarketScan® database was used to identify adults with PsA who
initiated therapy with a biologic (with first use identified as index date). Patients were …
以上显示的是最相近的搜索结果。 查看全部搜索结果